dx.doi.org/10.1093/annonc/mdy283.097, hdl.handle.net/1765/125531
Annals of Oncology
Erasmus MC: University Medical Center Rotterdam

Verhoeff, S.R. (S. R.), Es, S. (S.), Boon, E. (E.), van Helden, E. (E.), Angus, L, Elias, S.G, … Herpen, C.M.L. (2018). Lesion detection by ceCT, 89Zr-girentuximab and FDG PET/CT in newly diagnosed patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC). Annals of Oncology, 29, viii314–viii315. doi:10.1093/annonc/mdy283.097